The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study

BACKGROUND: People living with HIV (PLWH) have a worse prognosis than the general population. Locally advanced or metastatic bladder cancer (BCa) in PLWH has gradually been increasing in recent years. Immune checkpoint inhibitors can improve antitumor activity in the general population, but relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Menghua, Zheng, Xin, Wang, Xudong, Li, Xuyu, Zhang, Yu, Zhao, Jimao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155016/
https://www.ncbi.nlm.nih.gov/pubmed/37115019
http://dx.doi.org/10.1177/10732748231173475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155016/
https://www.ncbi.nlm.nih.gov/pubmed/37115019
http://dx.doi.org/10.1177/10732748231173475

Ejemplares similares